Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-11 Sale |
2023-07-13 1:55 pm |
IVERIC bio Inc. | ISEE | Bolte Axel Director |
22,088 | $0 | $0 | 0 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-20 4:05 pm |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
67,750 | $3.69 | $249,998 | 258,575 (Direct) |
View |
| 2021-06-24 Sale |
2021-06-25 07:58 am |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
66,788 | $0.0001 | $7 | 291,305 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-18 Option Award |
2024-06-20 4:09 pm |
N/A 2034-06-17 |
Inozyme Pharma Inc. | INZY | Bolte Axel Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:05 pm |
N/A 2033-06-12 |
Inozyme Pharma Inc. | INZY | Bolte Axel Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 5:55 pm |
N/A N/A |
IVERIC bio Inc. | ISEE | Bolte Axel Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 4:51 pm |
N/A N/A |
IVERIC bio Inc. | ISEE | Bolte Axel Director |
14,588 | $0 | 22,088 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 08:40 am |
N/A 2033-04-30 |
Inozyme Pharma Inc. | INZY | Bolte Axel Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 08:40 am |
N/A N/A |
Inozyme Pharma Inc. | INZY | Bolte Axel Director |
4,806 | $2.21 | 266,696 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-04 08:00 am |
N/A N/A |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
3,315 | $2.28 | 261,890 (Direct) |
View |
| 2022-05-12 Option Award |
2022-05-13 6:05 pm |
N/A N/A |
IVERIC bio Inc. | ISEE | Bolte Axel Director |
37,774 | $0 | 45,274 (Direct) |
View |
| 2022-05-11 Exercise |
2022-05-13 6:05 pm |
N/A N/A |
IVERIC bio Inc. | ISEE | Bolte Axel Director |
7,500 | $0 | 45,274 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 07:47 am |
N/A 2032-02-23 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2021-06-24 Exercise |
2021-06-25 07:58 am |
N/A 2027-06-27 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
66,788 | $0 | 291,305 (Direct) |
View |
| 2021-06-24 Exercise |
2021-06-25 07:58 am |
N/A N/A |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
66,788 | $0.98 | 291,305 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 7:51 pm |
N/A 2031-05-18 |
IVERIC bio Inc. | ISEE | Bolte Axel Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:56 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
117,000 | $0 | 117,000 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:14 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
225,975 | $0 | 225,975 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:48 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Bolte Axel See Remarks 10% Owner |
287,706 | $0 | 287,706 (Direct) |
View |
Ownership |
2020-07-23 9:20 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Bolte Axel See Remarks 10% Owner |
0 | $0 | 649,019 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-11 2:02 pm |
N/A N/A |
IVERIC bio Inc. | ISEE | Bolte Axel Director |
16,000 | $0 | 16,000 (Direct) |
View |